Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma

Daisuke Arai, Ahmed E. Hegab, Kenzo Soejima, Aoi Kuroda, Kota Ishioka, Hiroyuki Yasuda, Katsuhiko Naoki, Shizuko Kagawa, Junko Hamamoto, Yongjun Yin, David M. Ornitz, Tomoko Betsuyaku

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Fibroblast growth factor 9 (FGF9) is essential for lung development and is highly expressed in a subset of human lung adenocarcinomas. We recently described a mouse model in which FGF9 expression in the lung epithelium caused proliferation of the airway epithelium at the terminal bronchioles and led to rapid development of adenocarcinoma. Here, we used this model to characterize the effects of prolonged FGF9 induction on the proximal and distal lung epithelia, and examined the propagation potential of FGF9-induced lung tumours. We showed that prolonged FGF9 over-expression in the lung resulted in the development of adenocarcinomas arising from both alveolar type II and airway secretory cells in the lung parenchyma and airways, respectively. We found that tumour cells harboured tumour-propagating cells that were able to form secondary tumours in recipient mice, regardless of FGF9 expression. However, the highest degree of tumour propagation was observed when unfractionated tumour cells were co-administered with autologous, tumour-associated mesenchymal cells. Although the initiation of lung adenocarcinomas was dependent on activation of the FGF9-FGF receptor 3 (FGFR3) signalling axis, maintenance and propagation of the tumour was independent of this signalling. Activation of an alternative FGF-FGFR axis and the interaction with tumour stromal cells is likely to be responsible for the development of this independence. This study demonstrates the complex role of FGF-FGFR signalling in the initiation, growth and propagation of lung cancer. Our findings suggest that analysing the expressions of FGF-FGFRs in human lung cancer will be a useful tool for guiding customized therapy.

Original languageEnglish
Pages (from-to)593-605
Number of pages13
JournalJournal of Pathology
Volume235
Issue number4
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Fibroblast Growth Factor 9
Neoplasms
Lung
Epithelium
Lung Neoplasms
Adenocarcinoma
Bronchioles
Adenocarcinoma of lung
Mouse Fgf9 protein
Fibroblast Growth Factor Receptors
Stromal Cells
Maintenance

Keywords

  • Adenocarcinoma
  • FGF9
  • FGFR
  • Lung cancer
  • Tumour propagation
  • Tumour-associated lung fibroblasts

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma. / Arai, Daisuke; Hegab, Ahmed E.; Soejima, Kenzo; Kuroda, Aoi; Ishioka, Kota; Yasuda, Hiroyuki; Naoki, Katsuhiko; Kagawa, Shizuko; Hamamoto, Junko; Yin, Yongjun; Ornitz, David M.; Betsuyaku, Tomoko.

In: Journal of Pathology, Vol. 235, No. 4, 01.03.2015, p. 593-605.

Research output: Contribution to journalArticle

Arai, D, Hegab, AE, Soejima, K, Kuroda, A, Ishioka, K, Yasuda, H, Naoki, K, Kagawa, S, Hamamoto, J, Yin, Y, Ornitz, DM & Betsuyaku, T 2015, 'Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma', Journal of Pathology, vol. 235, no. 4, pp. 593-605. https://doi.org/10.1002/path.4486
Arai, Daisuke ; Hegab, Ahmed E. ; Soejima, Kenzo ; Kuroda, Aoi ; Ishioka, Kota ; Yasuda, Hiroyuki ; Naoki, Katsuhiko ; Kagawa, Shizuko ; Hamamoto, Junko ; Yin, Yongjun ; Ornitz, David M. ; Betsuyaku, Tomoko. / Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma. In: Journal of Pathology. 2015 ; Vol. 235, No. 4. pp. 593-605.
@article{1aea05861d6c4a19864db6b536cdfadd,
title = "Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma",
abstract = "Fibroblast growth factor 9 (FGF9) is essential for lung development and is highly expressed in a subset of human lung adenocarcinomas. We recently described a mouse model in which FGF9 expression in the lung epithelium caused proliferation of the airway epithelium at the terminal bronchioles and led to rapid development of adenocarcinoma. Here, we used this model to characterize the effects of prolonged FGF9 induction on the proximal and distal lung epithelia, and examined the propagation potential of FGF9-induced lung tumours. We showed that prolonged FGF9 over-expression in the lung resulted in the development of adenocarcinomas arising from both alveolar type II and airway secretory cells in the lung parenchyma and airways, respectively. We found that tumour cells harboured tumour-propagating cells that were able to form secondary tumours in recipient mice, regardless of FGF9 expression. However, the highest degree of tumour propagation was observed when unfractionated tumour cells were co-administered with autologous, tumour-associated mesenchymal cells. Although the initiation of lung adenocarcinomas was dependent on activation of the FGF9-FGF receptor 3 (FGFR3) signalling axis, maintenance and propagation of the tumour was independent of this signalling. Activation of an alternative FGF-FGFR axis and the interaction with tumour stromal cells is likely to be responsible for the development of this independence. This study demonstrates the complex role of FGF-FGFR signalling in the initiation, growth and propagation of lung cancer. Our findings suggest that analysing the expressions of FGF-FGFRs in human lung cancer will be a useful tool for guiding customized therapy.",
keywords = "Adenocarcinoma, FGF9, FGFR, Lung cancer, Tumour propagation, Tumour-associated lung fibroblasts",
author = "Daisuke Arai and Hegab, {Ahmed E.} and Kenzo Soejima and Aoi Kuroda and Kota Ishioka and Hiroyuki Yasuda and Katsuhiko Naoki and Shizuko Kagawa and Junko Hamamoto and Yongjun Yin and Ornitz, {David M.} and Tomoko Betsuyaku",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/path.4486",
language = "English",
volume = "235",
pages = "593--605",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma

AU - Arai, Daisuke

AU - Hegab, Ahmed E.

AU - Soejima, Kenzo

AU - Kuroda, Aoi

AU - Ishioka, Kota

AU - Yasuda, Hiroyuki

AU - Naoki, Katsuhiko

AU - Kagawa, Shizuko

AU - Hamamoto, Junko

AU - Yin, Yongjun

AU - Ornitz, David M.

AU - Betsuyaku, Tomoko

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Fibroblast growth factor 9 (FGF9) is essential for lung development and is highly expressed in a subset of human lung adenocarcinomas. We recently described a mouse model in which FGF9 expression in the lung epithelium caused proliferation of the airway epithelium at the terminal bronchioles and led to rapid development of adenocarcinoma. Here, we used this model to characterize the effects of prolonged FGF9 induction on the proximal and distal lung epithelia, and examined the propagation potential of FGF9-induced lung tumours. We showed that prolonged FGF9 over-expression in the lung resulted in the development of adenocarcinomas arising from both alveolar type II and airway secretory cells in the lung parenchyma and airways, respectively. We found that tumour cells harboured tumour-propagating cells that were able to form secondary tumours in recipient mice, regardless of FGF9 expression. However, the highest degree of tumour propagation was observed when unfractionated tumour cells were co-administered with autologous, tumour-associated mesenchymal cells. Although the initiation of lung adenocarcinomas was dependent on activation of the FGF9-FGF receptor 3 (FGFR3) signalling axis, maintenance and propagation of the tumour was independent of this signalling. Activation of an alternative FGF-FGFR axis and the interaction with tumour stromal cells is likely to be responsible for the development of this independence. This study demonstrates the complex role of FGF-FGFR signalling in the initiation, growth and propagation of lung cancer. Our findings suggest that analysing the expressions of FGF-FGFRs in human lung cancer will be a useful tool for guiding customized therapy.

AB - Fibroblast growth factor 9 (FGF9) is essential for lung development and is highly expressed in a subset of human lung adenocarcinomas. We recently described a mouse model in which FGF9 expression in the lung epithelium caused proliferation of the airway epithelium at the terminal bronchioles and led to rapid development of adenocarcinoma. Here, we used this model to characterize the effects of prolonged FGF9 induction on the proximal and distal lung epithelia, and examined the propagation potential of FGF9-induced lung tumours. We showed that prolonged FGF9 over-expression in the lung resulted in the development of adenocarcinomas arising from both alveolar type II and airway secretory cells in the lung parenchyma and airways, respectively. We found that tumour cells harboured tumour-propagating cells that were able to form secondary tumours in recipient mice, regardless of FGF9 expression. However, the highest degree of tumour propagation was observed when unfractionated tumour cells were co-administered with autologous, tumour-associated mesenchymal cells. Although the initiation of lung adenocarcinomas was dependent on activation of the FGF9-FGF receptor 3 (FGFR3) signalling axis, maintenance and propagation of the tumour was independent of this signalling. Activation of an alternative FGF-FGFR axis and the interaction with tumour stromal cells is likely to be responsible for the development of this independence. This study demonstrates the complex role of FGF-FGFR signalling in the initiation, growth and propagation of lung cancer. Our findings suggest that analysing the expressions of FGF-FGFRs in human lung cancer will be a useful tool for guiding customized therapy.

KW - Adenocarcinoma

KW - FGF9

KW - FGFR

KW - Lung cancer

KW - Tumour propagation

KW - Tumour-associated lung fibroblasts

UR - http://www.scopus.com/inward/record.url?scp=84922755064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922755064&partnerID=8YFLogxK

U2 - 10.1002/path.4486

DO - 10.1002/path.4486

M3 - Article

VL - 235

SP - 593

EP - 605

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 4

ER -